HOUSTON — Memorial Hermann is now offering genoME®, a community health research program developed through a strategic collaboration between Memorial Hermann and Helix. This program aims to uncover important information about a person's genetics that could impact their risk for certain conditions like breast and ovarian cancer, colorectal cancer and high cholesterol, as well as the health of their children.
By aiming to identify health risks before symptoms arise, providers and patients can make proactive decisions on care with the potential to delay, reduce or even prevent detrimental health effects. The program will also provide Memorial Hermann and its research partners with genomic data that will have lasting implications for critical health discoveries and improvements to patient care.
With an anticipated 100,000 participants, this will be one of the largest population health programs in Texas. Their vision is to create healthier communities now and for generations to come.
For more information about genoME®, visit MemorialHermann.org/genome-tv.
This content sponsored by Memorial Hermann Health System